Skip to main content
Journal cover image

Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage.

Publication ,  Journal Article
Belalcazar, A; Stahl, W; Friedman, DJ; Brouwer, TF; Knops, RE; Poole, JE; Kevin Heist, E
Published in: J Cardiovasc Electrophysiol
July 2023

INTRODUCTION: Transvenous implantable cardioverter-defibrillator (ICD) shocks have been associated with cardiac biomarker elevations and are thought in some cases to contribute to adverse clinical outcomes and mortality, possibly from myocardium exposed to excessive shock voltage gradients. Currently, there are only limited data for comparison with subcutaneous ICDs. We sought to compare ventricular myocardium voltage gradients resulting from transvenous (TV) and subcutaneous defibrillator (S-ICD) shocks to assess their risk of myocardial damage. METHODS: A finite element model was derived from thoracic magnetic resonance imaging (MRI). Voltage gradients were modeled for an S-ICD with a left-sided parasternal coil and a left-sided TV-ICD with a mid-cavity, a septal right ventricle (RV) coil, or a dual coil lead (TV mid, TV septal, TV septal +  superior vena cava [SVC]). High gradients were defined as > 100 V/cm. RESULTS: The volumes of ventricular myocardium with high gradients > 100 V/cm were 0.02, 2.4, 7.7, and 0 cc for TV mid, TV septal, TV septal + SVC, and S-ICD, respectively. CONCLUSION: Our models suggest that S-ICD shocks produce more uniform gradients in the myocardium, with less exposure to potentially damaging electrical fields, compared to TV-ICDs. Dual coil TV leads yield higher gradients, as does closer proximity of the shock coil to the myocardium.

Duke Scholars

Published In

J Cardiovasc Electrophysiol

DOI

EISSN

1540-8167

Publication Date

July 2023

Volume

34

Issue

7

Start / End Page

1561 / 1568

Location

United States

Related Subject Headings

  • Vena Cava, Superior
  • Subcutaneous Tissue
  • Myocardium
  • Humans
  • Heart Ventricles
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Belalcazar, A., Stahl, W., Friedman, D. J., Brouwer, T. F., Knops, R. E., Poole, J. E., & Kevin Heist, E. (2023). Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage. J Cardiovasc Electrophysiol, 34(7), 1561–1568. https://doi.org/10.1111/jce.15974
Belalcazar, Andres, Wyatt Stahl, Daniel J. Friedman, Tom F. Brouwer, Reinoud E. Knops, Jeanne E. Poole, and E. Kevin Heist. “Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage.J Cardiovasc Electrophysiol 34, no. 7 (July 2023): 1561–68. https://doi.org/10.1111/jce.15974.
Belalcazar A, Stahl W, Friedman DJ, Brouwer TF, Knops RE, Poole JE, et al. Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage. J Cardiovasc Electrophysiol. 2023 Jul;34(7):1561–8.
Belalcazar, Andres, et al. “Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage.J Cardiovasc Electrophysiol, vol. 34, no. 7, July 2023, pp. 1561–68. Pubmed, doi:10.1111/jce.15974.
Belalcazar A, Stahl W, Friedman DJ, Brouwer TF, Knops RE, Poole JE, Kevin Heist E. Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage. J Cardiovasc Electrophysiol. 2023 Jul;34(7):1561–1568.
Journal cover image

Published In

J Cardiovasc Electrophysiol

DOI

EISSN

1540-8167

Publication Date

July 2023

Volume

34

Issue

7

Start / End Page

1561 / 1568

Location

United States

Related Subject Headings

  • Vena Cava, Superior
  • Subcutaneous Tissue
  • Myocardium
  • Humans
  • Heart Ventricles
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology